Amgen Tells High Court Investor Class Hinges On Materiality
Amgen Inc. argued before the U.S. Supreme Court on Monday that plaintiffs in securities fraud suits should have to prove that allegedly misleading statements are material to a case for class...To view the full article, register now.
Already a subscriber? Click here to view full article